Oshqozon osti bezi neyroendokrin o'smalari (NETs) odatda sekin o'sadi va laboratoriya o'simtani o'sish belgilari uchun vizual tekshiruvlar orqali nazorat qiladi. Oshqozon osti bezidan NET tarqalishi bilan og'rigan bemorlarda odatda diareya yoki gormonal muammolar kabi alomatlar mavjud. Ular o'simta o'sishini inhibe qilishi mumkin bo'lgan oktreotid, lanreotid, diazoksid va proton pompasi inhibitörleri kabi dorilar uchun ishlatilishi mumkin.
When the patient’s symptoms cannot be controlled or the scan shows signs of shish growth, further treatment is required, and chemotherapy or targeted drugs (such as sunitinib or everolimus) can be used. For people with poorly differentiated tumors (neuroendocrine carcinoma), chemotherapy is the first choice. For patients who have spread to the liver, choose surgery or ablation technology for treatment according to their own conditions. For adults with somatostatin (a hormone) receptor-positive pancreatic neuroendocrine tumor, the radiopharmaceutical Lutathera (l Lu177 dotatate) is a treatment option.
Agar barcha mumkin bo'lgan muolajalar endi ishlamasa, yangi davolash usullarini sinab ko'rish uchun klinik sinovlarda ishtirok etishni o'ylab ko'ring. Klinik sinovlarda ishtirok etish ba'zi bemorlarga foyda keltirishi mumkin.
